Pulmonary Arterial Hypertension: all 773 studies

Page 2 of 8. Open to participants first (142), then studies with results posted, then the rest; newest registration first within each.

• REstoration of VItamin D in Pulmonary Arterial HypertensionNot yet recruitingNCT06258850Phase 4
• Clinical Trial of 2-HOBA in Pulmonary Arterial HypertensionNot yet recruitingNCT06176118Phase 2
• The Effects of the Otago Exercise ProgramNot yet recruitingNCT06172790Not applicable
• 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)RecruitingNCT06104228Phase 2
• IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated CardiomyopathyNot yet recruitingNCT06072937Not applicable
• Repurposing Valsartan May Protect Against Pulmonary HypertensionRecruitingNCT06053580Phase 2
• Assessing the Utility of Submaximal CPET in Treatment Management of PAHNot yet recruitingNCT05977933
• Anti-CD20 Antibodies for Treatment of SLE-PAHRecruitingNCT05828147Phase 4
• Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)RecruitingNCT05745961
• REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)RecruitingNCT05665556
• A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 TabletsNot yet recruitingNCT05660863Phase 1
• Telerehabilitation Program Via Videoconference PAH - Randomized Clinical TrialNot yet recruitingNCT05655481Not applicable
• Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)RecruitingNCT05587712Phase 2
• Artificial Intelligence-assisted Evaluation of Pulmonary HYpertensionRecruitingNCT05566002
• The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) StudyRecruitingNCT05464095Not applicable
• PET Image in PAH PatientsRecruitingNCT05452889Early Phase 1
• COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNginaRecruitingNCT05413109Not applicable
• National Registry and Cohort Study of Pulmonary Vascular DiseaseRecruitingNCT05368467
• A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruitingNCT05179876Phase 3
• Xenon MRI Pulm HypertensionRecruitingNCT04991454Phase 2
• Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial HypertensionRecruitingNCT04972656Not applicable
• Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling by invitationNCT04930289
• Pulmonary Hypertension Biorepository and RegistryRecruitingNCT04808596
• Pulmonary Hypertension SOLARRecruitingNCT04778046Phase 2
• Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension PatientsRecruitingNCT04756076
• TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal StudyNot yet recruitingNCT04570228Not applicable
• Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemRecruitingNCT04555161Not applicable
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT04278404
• Pulmonary Hypertension Association RegistryRecruitingNCT04071327
• Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAHRecruitingNCT04062565Phase 3
• DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PLRecruitingNCT03959748
• Multi-marker Approach for Risk Assessment in PAHRecruitingNCT03954405
• Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial HypertensionRecruitingNCT03835676Phase 4
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionEnrolling by invitationNCT03683186Phase 3
• Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt LesionsRecruitingNCT02691689Not applicable
• Pediatric Pulmonary Hypertension Network (PPHNet) Informatics RegistryRecruitingNCT02249923
• the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary HypertensionRecruitingNCT02061787
• Hormonal, Metabolic, and Signaling Interactions in PAHRecruitingNCT01884051
• Spironolactone for Pulmonary Arterial HypertensionRecruitingNCT01712620Phase 2
• Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos AiresRecruitingNCT01501838
• Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart DefectsRecruitingNCT01397110Not applicable
• COMPERA / COMPERA-KIDSRecruitingNCT01347216
• A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).TerminatedNCT05975905Phase 2Results posted
• A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)CompletedNCT05818137Phase 3Results posted
• Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension ParticipantsTerminatedNCT05764265Phase 2Results posted
• A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary HypertensionCompletedNCT05564637Phase 2Results posted
• Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)TerminatedNCT05557942Phase 3Results posted
• Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial HypertensionCompletedNCT05439460Phase 4Results posted
• A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial HypertensionCompletedNCT05167825Phase 3Results posted
• Study of Efficacy and Safety of LTP001 in Pulmonary Arterial HypertensionTerminatedNCT05135000Phase 2Results posted
• Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5CompletedNCT05039086Results posted
• Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPHTerminatedNCT04954742Phase 4Results posted
• Carnitine Consumption and Augmentation in Pulmonary Arterial HypertensionCompletedNCT04908397Phase 1Results posted
• A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)CompletedNCT04896008Phase 3Results posted
• Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)TerminatedNCT04811092Phase 3Results posted
• A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)TerminatedNCT04791514Phase 2Results posted
• A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)CompletedNCT04732221Phase 2/3Results posted
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)CompletedNCT04712669Phase 2Results posted
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)CompletedNCT04576988Phase 3Results posted
• GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT04456998Phase 2Results posted
• A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance ImagingTerminatedNCT04435782Phase 4Results posted
• Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat)CompletedNCT04316143Phase 2Results posted
• Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B StudyCompletedNCT04266197Phase 2Results posted
• Oral CXA-10 in Pulmonary Arterial HypertensionTerminatedNCT04125745Phase 2Results posted
• Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH SubjectsTerminatedNCT04084678Phase 3Results posted
• Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using TyvasoCompletedNCT03950739Phase 1Results posted
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT03904693Phase 3Results posted
• Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk TestCompletedNCT03893500Not applicableResults posted
• Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAHCompletedNCT03888365Results posted
• A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002)CompletedNCT03744637Phase 1Results posted
• A Study of Sotatercept for the Treatment of Pulmonary Arterial HypertensionCompletedNCT03738150Phase 2Results posted
• A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial HypertensionTerminatedNCT03657095Phase 3Results posted
• Effects of DHEA in Pulmonary HypertensionCompletedNCT03648385Phase 2Results posted
• Fluoxetine in Pulmonary Arterial Hypertension (PAH) TrialCompletedNCT03638908Phase 2Results posted
• Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary HypertensionCompletedNCT03554291Phase 2Results posted
• Tamoxifen Therapy to Treat Pulmonary Arterial HypertensionCompletedNCT03528902Phase 2Results posted
• EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial HypertensionCompletedNCT03497689Phase 4Results posted
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)CompletedNCT03496207Phase 2Results posted
• A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial HypertensionActive, not recruitingNCT03492177Phase 2Results posted
• Investigation of the Safety and Pharmacology of Dry Powder Inhalation of TreprostinilCompletedNCT03399604Phase 3Results posted
• The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial HypertensionCompletedNCT03273387Phase 2/3Results posted
• Pulmonary Hypertension and Anastrozole TrialCompletedNCT03229499Phase 2Results posted
• Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial HypertensionCompletedNCT03187678Phase 3Results posted
• A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT03177603Phase 2Results posted
• Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.CompletedNCT03078907Phase 4Results posted
• A Mobile Health Intervention in Pulmonary Arterial HypertensionCompletedNCT03069716Not applicableResults posted
• TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)CompletedNCT03055221Phase 4Results posted
• Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial HypertensionTerminatedNCT02981082Phase 1Results posted
• Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH PatientsTerminatedNCT02939599Phase 2Results posted
• A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)CompletedNCT02932410Phase 3Results posted
• Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH PatientsTerminatedNCT02927366Phase 2Results posted
• Estrogen Receptor Antagonist in Patients With Pulmonary Arterial HypertensionCompletedNCT02911844Phase 2Results posted
• Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapyCompletedNCT02891850Phase 4Results posted
• Crossover Study From Macitentan or Bosentan Over to AmbrisentanTerminatedNCT02885012Phase 4Results posted
• Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)CompletedNCT02847260Phase 4Results posted
• Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)TerminatedNCT02736149Phase 2Results posted
• Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAHCompletedNCT02734953Phase 2Results posted
• Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHTerminatedNCT02725372Phase 3Results posted
• Evaluation of a New Thermostable Formulation of FLOLAN in Japanese SubjectsCompletedNCT02705807Phase 4Results posted
• A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)CompletedNCT02664558Phase 2Results posted

← Pulmonary Arterial Hypertension overview